Separate names with a comma.
Pre-market DARE..Clinical stage Bio-Pharm focused on Women's reproductive health Up 55%..3.65 Float 35 million Investor Observer 96 out of 100 Tip...
One to watch GHSI..Health Science..Up 25% Tuesday .7999 Short term assets exceed Short and Long term liabilities Assets 12 million Debt 470K...
New out last night SRNE..Sorrento..9.43 Announced the presentation of preliminary results from ongoing Sars-Covid-19 mutation surveillance program...
SRNE..Taking a hit from Shorts Nice entry 9.35-9.45
One to watch LIXT..Up today 3.53 Just received approval to start Phase 1 Clinical Trial of their Lung Cancer Drug Fair Bid 3.25-3.30
ADMQ...083 Earnings just out Revenue 2020 tops Revenue for 2019 by 34%
ADMA..Up 15% this morning 2.34 News just out on earnings..4th quarter of 2020 13.9 million the best quarter ever since Company's inception. 2020...
NCTY..Nice entry 10.20-10.30
AVGR..Up 30% Friday to 1.47..Ticking up this morning 1.51 Buy and Hold Recommedation Catheter devices to treat vascular diseases Friday release...
INUV..Up 50% pre-market to 1.00 Developes and sells IT Solution Info based on previous close Projected to rise 43%..holding .66-1.00 Debt now only...
DBVT..Profiled last week Up again pre-market 35% 7.60 News late last week on success of peanut allergy patch
OBSV..Bio-Pharm therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Up 18% pre-market..4.80 Market...
News out this morning from Spain GRFS..19.08 Grifols will begin Clinical Trials of new treatment that would provide immediate immunity against...
SPONF...0079 Being pumped heavily next two days Look for initial push on tuesday,
NCNA..7.00 Up 7% Friday.. Nucana a Clinical-Stage Bio-Pharm focused on improving treatment outcomes for patients with cancer. Friday positive...
Should I stay or should I go..Will it go High or will I see it down Low SRNE..9.50..Sorrento Therapeutics on Friday UP 18% on four times the...
OCGN...2.20 India Starts Vaccinating its 1.3 Billion People Covishiels Vaccine developed by Astrazeneca and Oxford University and Covaxin...
SRNE..Opened today 8.15..Up 20% 9.60 Rose on news this morning..H.C. Wainwright analyst Ram Selvarajo raised Target Price from 25.00 to...
SRNE..8.85..Target Price raised to 30.00
NXTD..Down 7%..Nice Bid 1.27-1.29
